Development of a human study in the context of precision medicine associated to type 2 diabetes. Patients have been grouped according to their immune cells frequencies and are under investigation to speculate correlations between their transcriptome, the activation levels of specific genomic regulatory regions and the risk to develop to type 2 diabetes associated complications.